UNSPSC 51461505: Valerian

This classification denotes a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JWF5YAW3QW, which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 35363 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivision Angiospermae, Class Magnoliopsida, Superorder Asteranae, Order Dipsacales, Family Valerianaceae, Genus Valeriana L. (valerian), Species Valeriana officinalis L., commonly known as GARDEN HELIOTROPE, GARDEN VALERIAN, or as here, simple VALERIAN.

UNSPSC 51461505 Valerian is a Commodity code covering botanical and herbal pharmaceutical ingredients and finished products procured by state and local health systems, departments, and cooperative purchasing alliances. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, uses this classification family to source generic multi-source pharmaceuticals and over-the-counter products for distribution across participating state and local government facilities. State and local buyers under this code purchase finished pharmaceutical formulations and raw ingredients that meet current Good Manufacturing Practices (cGMP) and Drug Supply Chain Security Act (DSCSA) compliance; suppliers must demonstrate capability to distribute through established wholesaler networks (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) and provide detailed product specifications including National Drug Codes, UPCs, dosage forms, strengths, and manufacturing locations. Issuers include state health departments and multistate cooperative purchasing vehicles that aggregate demand across member jurisdictions to achieve volume-based pricing and standardized contracting terms. The scope extends to products with minimum one-year shelf life from manufacture and six-month remaining shelf life at delivery, with vendors bearing the cost of a 3 percent administrative fee on all contract purchases.

MMCAP's January 2026 RFP for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026, represents recent activity under this code. The procurement spans Minnesota and Oregon participating jurisdictions and seeks manufacturers willing to supply through multiple authorized wholesalers using flexible pricing structures—fixed price, net price formats (NF30, NF60, NF90), or WAC-minus arrangements. Award decisions favor price competitiveness (75 percent evaluation weight), with secondary criteria including fixed pricing transparency (10 percent), EDI capability (5 percent), administrative fee agreement (5 percent), and data format compliance (5 percent). Vendors must carry commercial general liability of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000. The contract term is two years for new responders with optional extensions, effective July 1, 2026, contingent on product market availability by May 15, 2026. No specific dollar values or set-aside designations are disclosed in the RFP.